Medco Pharma Spółkasp. z o.o. + limited partnership in liquidation
Manufacture of basic pharmaceutical products
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2019-02-04
Limited partner contribution
1,000.00 PLN
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Revenue history
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 3 of 6 financial statements were filed late (the longest delay 537 days for 2019), 2 not filed.
- 2025not filed
- 202416/07/2026
- 2023not filed
- 2022not filed
- 202105/04/2022
- 202005/04/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
- Retail sale in non-specialised stores (47.1)
Authorized Representatives
Anna Elżbieta Gałuszkaage 38 – Liquidator
Partners
| Partners |
|---|
Anna Elżbieta Gałuszkaage 38 |
Dominik Jakub Lipenskyage 37 |
Kajetan Filip Lipenskyage 32 |
Medco Sp. z o.o. |
Beneficial owners
No beneficial owners recorded for the company Medco Pharma Spółka.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Instytut Biotechnologii Surowic i Szczepionek Biomed - Skrót Firmy Ibss BiomedS.A. | $37,103,878.54 | biomed.pl | ||
| Fagronsp. z o.o. | $21,715,187.73 | fagron.pl | ||
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| F1 PharmaS.A. | $272,113.66 | f1pharma.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Zakład Farmaceutyczny Amarasp. j. | $0.00 | amara.pl | ||
| Grupa FinepharmS.A. | – | finepharm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2019-04-16 | Name change (Medco Pharma Spółka → Medco Pharma Spółka Spółka Z Ograniczoną Odpowiedzialnością Spółka Komandytowa W Likwidacji) | |
| 2019-03-19 | Liquidation opened | |
| 2019-02-04 | Entered in the register |
FAQ
The main business activity of Medco Pharma Spółka sp. z o.o. sp.k. focuses on manufacture of basic pharmaceutical products.
The company was registered in the Polish National Court Register (KRS) on February 4, 2019.
The headquarters is located at: ul. Piotra Skargi 22, 33-100 Tarnów.
The share capital of the company is PLN 1,000 (approx. $270).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
Last updated: 2026-07-16